PD1 ANTIBODY

Clinical trials for PD1 ANTIBODY explained in plain language.

Never miss a new study

Get alerted when new PD1 ANTIBODY trials appear

Sign up with your email to follow new studies for PD1 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail aims to stop bile duct cancer from coming back

Disease control Ongoing

This study tests whether giving a combination of immunotherapy (Toripalimab), a targeted drug (lenvatinib), and chemotherapy (GEMOX) before surgery can improve outcomes for people with a high-risk type of bile duct cancer. About 178 participants will be randomly assigned to recei…

Matched conditions: PD1 ANTIBODY

Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated May 11, 2026 20:37 UTC

PD1 ANTIBODY

Get alerted when new PD1 ANTIBODY trials appear

New drug cocktail aims to stop bile duct cancer from coming back